Abstract
The association between anthropometric indices with chronic kidney disease (CKD) was examined previously. However, the effect of body fat on renal function was not determined clearly. Our aim was to investigate the association of percent body fat (PBF) and renal function in adult population from health examination in Tri-Service General Hospital (2010–2016). 35087 participants aged 20 years and older were enrolled in the study. PBF was measured by bioelectrical impedance analysis (BIA). Estimation of renal function was performed by Taiwanese MDRD equation. Optimal cut-off values of PBF was accessed by a receiver–operator characteristic (ROC) curve analysis. Multivariate regression models were used in the relationship among changes of PBF, renal function, and future CKD. In terms of baseline PBF for CKD, optimal cut-off values of PBF in males and females were 21.55 and 40.75. The changes of PBF were more closely associated with renal function decline than waist circumference (WC) with β values of −0.173 (95% CI: −0.233, −0.112) and −0.077 (95% CI: −0.104, −0.049), respectively. After stratified by gender, this relationship remained significant in male population with β values of −0.276 (95% CI: −0.371, −0.181) and −0.159 (95% CI: −0.207, −0.112), respectively. Female subjects with increased baseline PBF over cut-off values had increased risk for predicting the future CKD with odd ratios (ORs) of 2.298 (95% CI: 1.006–5.252). Body fat had detrimental impact on renal function and development of CKD in adult population. Measurement of PBF for surveillance of renal function impairment was warranted.
Similar content being viewed by others
Introduction
Chronic kidney disease (CKD) was an emerging public health problem worldwide and increased incident and prevalence of end-stage renal disease (ESRD) was noted in Taiwan1. Impact of CKD elevated risk of all-cause mortality and cardiovascular diseases. Obesity was also a common risk factor for developing cardiovascular disease and metabolic syndrome in Taiwan2,3. Previous studies had reported the relationship between obesity with renal function by using different anthropometric parameters. The risk of developing incident CKD was higher in the obese defined by body mass index (BMI) than normal weight subjects4. In a previous study, waist-to-hip ratio (WHR) had more close association with the incident CKD and mortality rather than BMI5. Madero et al. demonstrated that visceral adipose tissue had significant association with renal function decline and had risk of developing CKD6.
Percent body fat (PBF) was suggested as a more valid predictor than BMI for the risk of cardiovascular diseases and other adverse outcomes7. In a Korean study, increased PBF was significantly associated with inflammation and decline of renal function among elderly population. However, it appeared that little research findings were available concerning the effect of PBF variation on renal function in adult population. The objective of our study was to investigate whether PBF would contribute to the change of renal function in adult population from Taiwan.
Results
The demographic characteristics of study sample
Characteristics of both male and female participants attended baseline examination and completed second visit were listed in Table 1. The mean age of baseline visit and second visit in males and females were 38.85 ± 14.57, 39.79 ± 14.81 and 41.10 ± 16.03, 42.16 ± 16.15 years, respectively. The values of MDRDGFR were 100.62 ± 18.31, 100.36 ± 18.50 and 108.38 ± 22.40, 108.58 ± 22.97, respectively. The values of eGFR were 102.62 ± 15.22, 102.15 ± 15.46 and 120.84 ± 16.03, 120.30 ± 16.34, respectively. The prevalence of obesity was increased in second visit that 21.6% in males and 12.0% in females. Anthropometric parameters including BMI, PBF, and waist circumference (WC) and biochemical data had significant differences across these groups. There were significantly increased PBF, WC and decreased eGFR between baseline and second visit in both genders.
Association among changes of PBF, WC and changes of renal function during follow-up
In Table 2, the changes of PBF and WC had significant associations with the changes of estimated glomerular filtration rate (eGFR) during the follow-up period. After multivariable adjustment, increased PBF had more closely associated with reduced renal function than WC with β values of −0.174, −0.172 and −0.173 (95% confidence interval (CI) = −0.234, −0.114; −0.233, −0.112; −0.233, −0.112) in each model, respectively.
Gender differences in the association among changes of PBF, WC and changes of renal function were also presented in Table 3. Both PBF and WC had negative relationship with the changes of eGFR, especially in male population. The increased β values of PBF was higher than those of WC in each adjusted model.
Hazard ratios for predicting the changes of renal function stratified by gender
Adjusted hazard ratios (HRs) of the changes of PBF and WC for predicting the changes of renal function in males and females were presented in Table 4. However, no significant difference was noted among the adjusted models in the changes of PBF or WC among both genders.
Adjusted odds ratios for developing CKD stratified by gender
Because the Cox proportional hazard models did not show any significant effect of the changes of PBF and WC on renal function, we further determined gender specific cut-off values of baseline PBF for CKD. Optimal cut-off values of baseline PBF categorized by gender were assessed by using receiver–operator characteristic (ROC) curve analysis in our study (Table 5). In male population, the area under the ROC (AUROC) value was 0.531 (95% CI: 0.425–0.637) and the optimal cut-off value was 21.55 with sensitivity and specificity of 85% and 30%. In females, the AUROC value was 0.613 (95% CI: 0.547–0.680) and the optimal cut-off value was 40.75 with sensitivity and specificity of 30% and 91%.
Association between the optimal cut-off values of baseline PBF with the presence of the future CKD was shown in Table 6. Female participants with increased PBF that over cut-off values had increased risks for predicting the presence of future CKD with ORs of 2.679, 2.360 and 2.298 (95%CI = 1.203–5.964; 1.039–5.363; 1.006–5.252) in each adjusted model, respectively. There was no interaction between cut-off values of baseline PBF and the future CKD. The interaction term between these factors was not significant in all models (P > 0.05).
Discussion
In our study, we highlighted the detrimental impact of body fat accumulation in the decline of renal function in general population derived from the longitudinal analysis of health examinations. Particularly, female participants with higher baseline PBF over cut-off values had higher risks of developing future CKD. To the best of our knowledge, the present study was the first to explore the relationship between PBF and renal function, defined by Taiwanese MDRD equation, and predict the risk of future CKD by baseline PBF in a large population-based survey which was composed of general population in Taiwan.
The interactions between obesity and renal function had been reported in previous studies. In a cross-sectional observational study, subjects with increased BMI was suggested to have increased risk of CKD8. Boer et al. demonstrated that obesity was associated with a decline in GFR in a community-based population of older adults9. Central body fat distribution was significantly associated with impaired renal function10. Increased abdominal obesity, defined by WC and WHR, was positively related to renal function impairment in Chinese population11. In a prospective study composed of 390 elderly participants, Oh et al. proposed that a change in PBF was associated with a decline in eGFR estimated by CKD-EPI equation that the highest tertile of change in PBF had increased risk for rapid progression of renal dysfunction12. It was similar with our findings that changes of PBF had adverse effect on renal function. However, the estimation of GFR in the present study was used by Taiwanese MDRD equation, which was more suitable for Taiwanese adults than other measurements13. In addition, the study sample was obtained from a large-scale general population. PBF also had predictive ability for the future CKD in female population by a longitudinal analysis.
The exact mechanisms of obesity on renal function decline was unclear. Numerous studies had reported that deteriorated renal consequences by adipose tissue might include inflammation, insulin resistance and renin-angiotensin-aldosterone system (RAAS). Various cytokines such as interleukin-6 (IL-6), IL-8, IL-10 and tumor necrosis factor-alpha (TNF-alpha) were released by adipose tissue in obese subjects14. Increased production and decreased clearance of pro-inflammatory cytokines was proposed to cause chronic inflammatory status in CKD15. Emerging evidence had considered adipose tissue as an important endocrine organ which produced adiponectin, leptin, and resistin16,17,18. These hormones could lead to insulin resistance and activate progression of renal disease by worsening renal hemodynamics by several pathways including sympathetic nervous system excitation, sodium retention and downregulation of the natriuretic peptide system19. The RAAS was well known for regulating blood pressure and determining target-organ damage20. Angiotensin II was the key factor of the RAAS to increase the glomerular hydraulic pressure and the ultrafiltration of plasma proteins predominantly by vasoconstrictor effect of post glomerular arterioles, leading to the onset and progression of chronic renal damage21. Adipose tissue was regarded as the source of angiotensin that a local RAAS was present in human adipose tissue22. Besides, increased angiotensinogen produced by adipose tissue might be responsible in part for the metabolic and inflammatory disorders that associated with chronic renal diseases23.
General female subjects with increased baseline PBF over the optimal cut-off values had increased likelihood for predicting the future CKD in our study. Sex difference in adipose tissue might be multifactorial. Females experienced a continuous increase in PBF throughout development and they had higher PBF than males during puberty24. Leptin was primarily produced by adipose tissue with circulating levels being positively correlated with total body fat25. Hellstrom et al. reported the gender difference in circulating leptin concentrations that females had higher levels than males26. Renal function decline was caused by increased leptin via triggering a paracrine interaction in proliferation of glomerular endothelial cells, exerting sympathetic nervous activity, and inducing reactive oxygen species17.
The strengths of our study are a large population-based survey, appropriate renal function measurement for the study sample, and a cohort analysis for the association between PBF and risks of the future CKD. However, there are several potential limitations among our study. First, the dataset was derived from only an Asian population. Therefore, the limited ethnicity diversity in the participants might not reflect the interaction in terms of racial differences. Second, the measurement of body composition among the study was used by BIA but not by DEXA, the standard method for measuring body fat and muscle mass in general. Next, the biological mechanism through which PBF acted on renal function were not well elucidated. Further researches into the potential underpinnings of the relationship were needed. Last, the information about menopause and postmenopausal years of female participants was unavailable in our study. Sex hormones strongly influence body fat distribution and adipocyte differentiation27. Previous studies have reported that menopause-related changes in body fat distribution had risk of cardiometabolic diseases during postmenopausal years28. Decrease in estrogen secretion is considered to have a significant effect of obesity in menopausal females29.
Conclusion
Our findings demonstrated the association between the changes of PBF and the decline of renal function in adult population in Taiwan. PBF might be used to predict the risk of the future CKD, particularly in females. Measurement of body fat might provide as a useful tool for surveillance of renal function decline in adult population.
Methods
Study design
The present study was performed in the health examinations of Tri-Service General Hospital (TSGH) from 2010 to 2016. Study approval was conduct by the Institutional Review Board (IRB) of TSGH. The TSGH IRB waived the need to obtain individual informed consent because these data were analyzed anonymously. All methods were performed in accordance with the relevant guidelines and regulations of TSGH IRB. The flow chart of the study was shown in Fig. 1. participants who finished biochemical examination, body composition measurement, and renal function measurement at baseline and second visit were included (male: 18514/female: 16573).
Measurement of renal function
Previous studies had indicated that eGFR using the Modification of Diet in Renal Disease (MDRD) or Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations might not be accurate for Asians30,31. Thus, specialists in Japan, China and Thailand subsequently presented different estimations suitable for their citizens32,33,34. In our study, eGFR was estimated by Taiwanese MDRD equation, reported by Chen et al., which was better than other renal function equations for Taiwanese adults13. The formula of Taiwanese MDRD equation was 1.3096 X MDRD0.912. Serum creatinine (Cr) was measured by the uncompensated Jaffe method with the alkaline picrate kinetic test.
Diagnosis of chronic kidney disease
According to the definition of the Kidney Disease Outcomes Quality Initiative (KDOQI), individuals with a GFR <60 ml/min/1.73 m2 for 3 months were identified as having CKD, irrespective of the presence or absence of kidney damage35. Markers of kidney damage included: hematuria, electrolyte abnormalities, structural abnormalities detected by imaging36.
Measurement of body composition
BMI was generally used as an attempt to quantify the amount of tissue mass in an individual and a standard for recording obesity37. BMI was estimated based on a general formula that the weight of the in kilograms divided by the square of the height in meters (kg/m2) of a participant (kg/m2). WC was measured at mid-level between the iliac crest and the lower border of the 12th rib. Bioelectrical impedance analysis (BIA) was an effective and valid method for assessing body composition38. It was an alternative to more invasive and expensive methods like dual-energy X-ray absorptiometry, computerized tomography, and magnetic resonance imaging. In the present study, we detected PBF by using BIA (InBody720, Biospace, Inc., Cerritos, CA, USA).
Covariates measurement
Biochemical data were collected by drawing blood samples from subjects after fasting for at least 8 hours. Fasting plasma glucose (FPG) was detected using a glucose oxidase method. Aspartate transaminase (AST) was measured by an enzymatic colorimetric method. The latex-enhanced nephelometry was used to detect high sensitivity C-reactive protein (hsCRP). Uric acid (UA) was measured by the Hitachi 737 automated multichannel chemistry analyzer (Boehringer Mannheim Diagnostics, Indianapolis, IN, USA). Thyroid stimulating hormone (TSH) was accessed by an immune-enzymatic assay. High density lipoprotein cholesterol (HDL-C) were analyzed by using an enzymatic colorimetric method. All experimental methods were performed in accordance with the relevant guidelines and regulations of TSGH.
Statistical analysis
Statistical estimations used in the study were performed by the Statistical Package for the Social Sciences, version18.0 (SPSS Inc., Chicago, IL, USA) for Windows. The differences between males and females in terms of demographic information and biochemistry data were examined by Student’s t test and Pearson’s chi-square test. A two-sided p-value of ≤0.05 was regarded as the threshold for statistical significance. A ROC curve was used to calculate the scores of baseline PBF to predict the presence of CKD, including gender specific cut-off values, AUROC and the corresponding 95%CI. Extend-model approach was performed in the study with multivariable adjustment for pertinent clinical variables as follows: Model 1 included age, gender, and BMI; Model 2 included Model 1 plus proteinuria, UA, AST, albumin, TSH, hsCRP, FPG, and HDL-C; Model 3 included Model 2 plus history of smoking, hypertension (HTN), and diabetes mellitus (DM). A multivariable linear regression model was performed for the association between the changes of PBF and WC with the changes of renal function. A proportional Cox hazard regression model was conducted for the changes of PBF and WC to predict the incident changes of eGFR during the follow-up. A multivariable logistic regression was used for the associations between cut-off values of baseline PBF and the future CKD.
References
Hwang, S. J., Tsai, J. C. & Chen, H. C. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton, Vic.) 15(Suppl 2), 3–9, https://doi.org/10.1111/j.1440-1797.2010.01304.x (2010).
Huang, K. C. Obesity and its related diseases in Taiwan. Obesity reviews: an official journal of the International Association for the Study of Obesity 9(Suppl 1), 32–34, https://doi.org/10.1111/j.1467-789X.2007.00435.x (2008).
Hwang, L. C., Bai, C. H. & Chen, C. J. Prevalence of obesity and metabolic syndrome in Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi 105, 626–635, https://doi.org/10.1016/s0929-6646(09)60161-3 (2006).
Lai, Y. J. et al. Association between obesity and risk of chronic kidney disease: A nationwide Cohort study in Taiwan. Nutrition, metabolism, and cardiovascular diseases: NMCD 27, 1008–1014, https://doi.org/10.1016/j.numecd.2017.08.006 (2017).
Elsayed, E. F. et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. American journal of kidney diseases: the official journal of the National Kidney Foundation 52, 29–38, https://doi.org/10.1053/j.ajkd.2008.02.363 (2008).
Madero, M. et al. Comparison between Different Measures of Body Fat with Kidney Function Decline and Incident CKD. Clinical journal of the American Society of Nephrology: CJASN 12, 893–903, https://doi.org/10.2215/cjn.07010716 (2017).
Zeng, Q., Dong, S.-Y., Sun, X.-N., Xie, J. & Cui, Y. Percent body fat is a better predictor of cardiovascular risk factors than body mass index. Brazilian Journal of Medical and Biological Research 45, 591–600, https://doi.org/10.1590/S0100-879X2012007500059 (2012).
Nomura, I., Kato, J. & Kitamura, K. Association between body mass index and chronic kidney disease: A population-based, cross-sectional study of a Japanese community. Vascular Health and Risk Management 5, 315–320 (2009).
de Boer, I. H. et al. Obesity and Change in Estimated GFR Among Older Adults. American journal of kidney diseases: the official journal of the National Kidney Foundation 54, 1043–1051, https://doi.org/10.1053/j.ajkd.2009.07.018 (2009).
Pinto-Sietsma, S. J. et al. A central body fat distribution is related to renal function impairment, even in lean subjects. American journal of kidney diseases: the official journal of the National Kidney Foundation 41, 733–741 (2003).
He, Y. et al. The association of chronic kidney disease and waist circumference and waist-to-height ratio in Chinese urban adults. Medicine 95, e3769, https://doi.org/10.1097/MD.0000000000003769 (2016).
Oh, S. W. et al. Relationship between Changes in Body Fat and a Decline of Renal Function in the Elderly. PLoS ONE 9, e84052, https://doi.org/10.1371/journal.pone.0084052 (2014).
Chen, L.-I. et al. Modification of Diet in Renal Disease (MDRD) Study and CKD Epidemiology Collaboration (CKD-EPI) Equations for Taiwanese Adults. PLoS ONE 9, e99645, https://doi.org/10.1371/journal.pone.0099645 (2014).
Fain, J. N. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitamins and hormones 74, 443–477, https://doi.org/10.1016/s0083-6729(06)74018-3 (2006).
Akchurin, O. M. & Kaskel, F. Update on inflammation in chronic kidney disease. Blood Purif 39, 84–92, https://doi.org/10.1159/000368940 (2015).
Sharma, K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney international 76, 145–148, https://doi.org/10.1038/ki.2009.137 (2009).
Wolf, G. & Ziyadeh, F. N. Leptin and renal fibrosis. Contributions to nephrology 151, 175–183, https://doi.org/10.1159/000095328 (2006).
Ellington, A. A. et al. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension (Dallas, Tex.: 1979) 50, 708–714, https://doi.org/10.1161/hypertensionaha.107.095257 (2007).
Spoto, B., Pisano, A. & Zoccali, C. Insulin resistance in chronic kidney disease: a systematic review. American journal of physiology. Renal physiology 311, F1087–f1108, https://doi.org/10.1152/ajprenal.00340.2016 (2016).
Muñoz-Durango, N. et al. Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension. International Journal of Molecular Sciences 17, 797, https://doi.org/10.3390/ijms17070797 (2016).
Remuzzi, G., Perico, N., Macia, M. & Ruggenenti, P. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney international. Supplement, S57–65, https://doi.org/10.1111/j.1523-1755.2005.09911.x (2005).
Ailhaud, G. et al. Angiotensinogen, angiotensin II and adipose tissue development. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 24(Suppl 4), S33–35 (2000).
Yvan-Charvet, L. & Quignard-Boulange, A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney international 79, 162–168, https://doi.org/10.1038/ki.2010.391 (2011).
Gallagher, D. et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? American journal of epidemiology 143, 228–239 (1996).
Considine, R. V. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England journal of medicine 334, 292–295, https://doi.org/10.1056/nejm199602013340503 (1996).
Hellstrom, L., Wahrenberg, H., Hruska, K., Reynisdottir, S. & Arner, P. Mechanisms behind gender differences in circulating leptin levels. Journal of internal medicine 247, 457–462 (2000).
Haffner, S. M., Valdez, R. A., Stern, M. P. & Katz, M. S. Obesity, body fat distribution and sex hormones in men. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 17, 643–649 (1993).
Toth, M. J., Tchernof, A., Sites, C. K. & Poehlman, E. T. Menopause-related changes in body fat distribution. Annals of the New York Academy of Sciences 904, 502–506 (2000).
Lizcano, F. & Guzmán, G. Estrogen Deficiency and the Origin of Obesity duringMenopause. BioMed Research International 2014, 757461, https://doi.org/10.1155/2014/757461 (2014).
Zuo, L. et al. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. American journal of kidney diseases: the official journal of the National Kidney Foundation 45, 463–472, https://doi.org/10.1053/j.ajkd.2004.11.012 (2005).
Imai, E. et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clinical and experimental nephrology 11, 41–50, https://doi.org/10.1007/s10157-006-0453-4 (2007).
Matsuo, S. et al. Revised equations for estimated GFR from serum creatinine in Japan. American journal of kidney diseases: the official journal of the National Kidney Foundation 53, 982–992, https://doi.org/10.1053/j.ajkd.2008.12.034 (2009).
Ma, Y. C. et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Journal of the American Society of Nephrology: JASN 17, 2937–2944, https://doi.org/10.1681/asn.2006040368 (2006).
Praditpornsilpa, K. et al. The need for robust validation for MDRD-based glomerular filtration rate estimation in various CKD populations. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 26, 2780–2785, https://doi.org/10.1093/ndt/gfq815 (2011).
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American journal of kidney diseases: the official journal of the National Kidney Foundation 39, S1–266 (2002).
National Collaborating Centre for Chronic, C. in Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care (Royal College of Physicians (UK) Royal College of Physicians of London., 2008).
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet (London, England) 363, 157–163, https://doi.org/10.1016/s0140-6736(03)15268-3 (2004).
Sergi, G., De Rui, M., Stubbs, B., Veronese, N. & Manzato, E. Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons. Aging clinical and experimental research 29, 591–597, https://doi.org/10.1007/s40520-016-0622-6 (2017).
Author information
Authors and Affiliations
Contributions
Yuan-Yuei Chen contributed to the design of the study, was responsible for the management and retrieval of data, contributed to initial data analysis and interpretation, drafted the initial manuscript. Yuan-Yuei Chen, Wen-Hui Fang, Chung-Ching Wang, Tung-Wei Kao, Yaw-Wen Chang, Hui-Fang Yang, Chen-Jung Wu, Yu-Shan Sun, Wei-Liang Chen decided upon the data collection methods. Yuan-Yuei Chen and Wei-Liang Chen were also responsible for the data analysis decisions. Wei-Liang Chen conceptualized and designed the study, supervised all aspects of the study, critically reviewed and revised the manuscript, and approved the final manuscript as submitted. All authors meet the ICMJE criteria for authorship.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, YY., Fang, WH., Wang, CC. et al. Changes of Percent Body Fat as a Useful Surrogate for Risk of Declined Renal Function. Sci Rep 8, 17289 (2018). https://doi.org/10.1038/s41598-018-35601-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-35601-2
Keywords
This article is cited by
-
Lowering the percent body fat in the obese population might reduce male lower urinary tract symptoms
World Journal of Urology (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.